SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-22-008144
Filing Date
2022-12-02
Accepted
2022-12-02 06:01:11
Documents
1
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3055
  Complete submission text file 0001683168-22-008144.txt   4665
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 14464 GOUIN W. #B MONTREAL A8 H9H 1B1
Business Address
Sebaaly Camille (Reporting) CIK: 0001474695 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41282 | Film No.: 221440194